Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,749,300 | 2,261,400 | 1,541,800 | 1,742,000 | 1,217,500 |
| Marketable Securities | 2,002,400 | 1,541,100 | 1,413,300 | 1,308,800 | 1,320,000 |
| Receivables | 1,632,000 | 1,549,400 | 1,723,000 | 1,688,000 | 1,854,300 |
| Inventories | 1,215,400 | 1,351,500 | 1,347,900 | 1,254,800 | 1,171,800 |
| Other current assets | 1,316,800 | 1,153,100 | 1,136,300 | 1,190,100 | 1,155,900 |
| TOTAL | $7,915,900 | $7,856,500 | $7,162,300 | $7,183,700 | $6,719,500 |
| Non-Current Assets | |||||
| PPE Net | 3,372,800 | 3,416,400 | 3,410,700 | 3,442,200 | 3,438,300 |
| Investments And Advances | 2,769,100 | 2,831,500 | 2,986,900 | 3,443,200 | 3,244,900 |
| Intangibles | 7,908,800 | 7,982,400 | 8,047,300 | 8,148,900 | 8,751,200 |
| Other Non-Current Assets | 1,647,800 | 1,790,500 | 2,199,500 | 2,252,400 | 1,700,800 |
| TOTAL | $15,698,500 | $16,020,800 | $16,644,400 | $17,286,700 | $17,135,200 |
| Total Assets | $23,614,400 | $23,877,300 | $23,806,700 | $24,470,400 | $23,854,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 398,700 | 589,200 | 427,900 | 375,300 | 430,400 |
| Accrued Expenses | 2,231,100 | 2,535,200 | 2,550,700 | 2,741,000 | 2,592,300 |
| TOTAL | $3,946,600 | $4,298,200 | $4,211,600 | $3,347,200 | $3,165,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,275,700 | 6,274,000 | 6,272,300 | 7,269,200 | 7,267,200 |
| aiOther Non-Current Liabilities | 1,685,501 | 2,039,700 | 1,677,500 | 1,143,300 | 1,797,400 |
| TOTAL | $8,447,101 | $8,619,400 | $8,713,400 | $9,908,400 | $10,025,700 |
| Total Liabilities | $12,393,700 | $12,917,600 | $12,925,000 | $13,255,600 | $13,191,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,452 | 146,963 | 146,893 | 149,033 | 150,555 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 14,215,500 | 13,911,700 | 13,543,500 | 13,900,700 | 13,833,500 |
| Other shareholders' equity | -136,900 | -43,300 | 315,100 | 291,000 | -193,400 |
| TOTAL | $11,220,700 | $10,959,700 | $10,881,700 | $11,214,800 | $10,663,200 |
| Total Liabilities And Equity | $23,614,400 | $23,877,300 | $23,806,700 | $24,470,400 | $23,854,700 |